Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Bioconjug Chem. 2012 Dec 4;23(12):2377–2385. doi: 10.1021/bc3003919

Figure 5.

Figure 5

Top row: Images after administration of 1 nmol Cy7-3 at (left to right) 1, 4, and 24 h postinjection, as well as images of the excised organs at 24 h postinjection. Bottom row: Image after administration of 1 nmol Cy7-3 + 1 mmol DCIBzL, a high-affinity ligand for PSMA (blocker) at same time points as above. Note lack of uptake in the mice treated with DCIBzL, indicating binding specificity.